1. Global Market – Executive Summary
1.1. Global Market Overview
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Fact.MR Analysis and Recommendations
2. Global Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Introduction and Definition
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on
3.1.2. COVID-19 Crisis and Impact on Aprotic Solvent Prices
3.1.3. COVID-19 Impact Benchmark with Previous Crisis
3.1.3.1. Change in Demand
3.1.3.2. Before and After COVID-19 Crisis (Projected)
3.1.3.3. Before and After Sub-prime Crisis – 2008 (Actual)
3.1.3.4. Change in Demand post Recovery Period (After Each Crisis)
3.1.4. Impact on Market and Value (US$ Mn)
3.1.4.1. Likely Loss of Value in 2022
3.1.4.2. Mid-term and Long Term Forecast
3.1.4.3. Quarter by Quarter Demand and Recovery Assessment
3.1.5. Anticipated Demand and Value Recovery Curve
3.1.5.1. Likelihood of U-Shape Recovery
3.1.5.2. Likelihood of L-Shape Recovery
3.1.6. Recovery Period Assessment by Key Countries
3.1.7. Recovery Assessment by Key Market Segments
3.1.8. Action Points and Recommendations for Suppliers
3.1.9. Impact on Trade Balance
3.2. Key Trends Impacting the Market
3.3. Formulation and Source Development Trends
4. Market Background and foundation Data Points
4.1. Need of the Hour for Industries
4.2. Industry Wise Industry 4.0
4.3. Strategic Priorities
4.4. Life Cycle Stage
4.5. Importance of Technology
4.6. Use Cases of Paresthesia Treatment
4.7. Forecast Factors: Relevance and Impact
4.8. Investment Feasibility Matrix
4.9. PESTLE Analysis
4.10. Porter’s Five Forces Analysis
4.11. Market Dynamics
4.11.1. Drivers
4.11.2. Restraints
4.11.3. Opportunity Analysis
4.11.4. Trend
5. Global Market Demand (US$ Mn) Analysis 2018 to 2022 and Forecast, 2023 to 2033
5.1. Historical Market Value (US$ Mn) Analysis, 2018 to 2022
5.2. Current and Future Market Value (US$ Mn) Projections, 2023 to 2033
5.2.1. Y-o-Y Growth Trend Analysis
5.2.2. Absolute $ Opportunity Analysis
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type
6.1. Introduction / Key Findings
6.2. Historical Market Value (US$ Mn) Analysis By Type, 2018 to 2022
6.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Type, 2023 to 2033
6.3.1. Acute Paresthesia
6.3.2. Chronic Paresthesia
6.4. Market Attractiveness Analysis By Type
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Treatment
7.1. Introduction / Key Findings
7.2. Historical Market Value (US$ Mn) Analysis By Treatment, 2018 to 2022
7.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Treatment, 2023 to 2033
7.3.1. Immunosuppressants
7.3.2. Anticonvulsants
7.3.3. Topical Creams
7.3.4. Antivirals
7.4. Market Attractiveness Analysis By Treatment
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by End User
8.1. Introduction / Key Findings
8.2. Historical Market Value (US$ Mn) Analysis By End User, 2018 to 2022
8.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By End User, 2023 to 2033
8.3.1. Hospitals
8.3.2. Clinics
8.3.3. Diagnosis Centers
8.4. Market Attractiveness Analysis By End User
9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Region
9.1. Introduction / Key Findings
9.2. Historical Market Value (US$ Mn) Analysis By Region, 2018 to 2022
9.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. East Asia
9.3.5. South Asia & Oceania
9.3.6. Middle East and Africa (MEA)
9.4. Market Attractiveness Analysis By Region
10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
10.1. Introduction / Key Findings
10.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022
10.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2023 to 2033
10.3.1. By Country
10.3.1.1. United States
10.3.1.2. Canada
10.3.2. By Type
10.3.3. By Treatment
10.4. Market Attractiveness Analysis
10.4.1. By Country
10.4.2. By Type
10.4.3. By Treatment
11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022
11.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033
11.3.1. By Country
11.3.1.1. Brazil
11.3.1.2. Mexico
11.3.1.3. Rest of Latin America
11.3.2. By Type
11.3.3. By Treatment
11.3.4. By End User
11.4. Market Attractiveness Analysis
11.4.1. By Country
11.4.2. By Type
11.4.3. By Treatment
11.4.4. By End User
12. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022
12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033
12.3.1. By Country
12.3.1.1. Germany
12.3.1.2. France
12.3.1.3. Italy
12.3.1.4. Spain
12.3.1.5. United Kingdom
12.3.1.6. BENELUX
12.3.1.7. Russia
12.3.1.8. Rest of Europe
12.3.2. By Type
12.3.3. By Treatment
12.3.4. By End User
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Type
12.4.3. By Treatment
12.4.4. By End User
13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033
13.1. Introduction / Key Findings
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022
13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033
13.3.1. By Country
13.3.1.1. China
13.3.1.2. Japan
13.3.1.3. South Korea
13.3.2. By Type
13.3.3. By Treatment
13.3.4. By End User
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Type
13.4.3. By Treatment
13.4.4. By End User
14. South Asia & Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033
14.1. Introduction / Key Findings
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022
14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033
14.3.1. By Country
14.3.1.1. India
14.3.1.2. Thailand
14.3.1.3. Malaysia
14.3.1.4. Singapore
14.3.1.5. Vietnam
14.3.1.6. ANZ
14.3.1.7. Rest of South Asia & Oceania
14.3.2. By Type
14.3.3. By Treatment
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Type
14.4.3. By Treatment
14.4.4. By End User
15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033
15.1. Introduction / Key Findings
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022
15.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033
15.3.1. By Country
15.3.1.1. GCC Countries
15.3.1.2. South Africa
15.3.1.3. Israel
15.3.1.4. Rest of Middle East and Africa (MEA)
15.3.2. By Type
15.3.3. By Treatment
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Type
15.4.3. By Treatment
15.4.4. By End User
16. Market Structure Analysis
16.1. Market Analysis by Tier of Companies
16.2. Market Concentration
16.3. Market Share Analysis of Top Players
16.4. Market Presence Analysis
17. Competition Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Competition Deep Dive
17.3.1. Boston Scientific Corporation
17.3.1.1. Company Overview
17.3.1.2. Source overview
17.3.1.3. SWOT Analysis
17.3.1.4. Key Developments
17.3.2. Baxter International Inc.
17.3.2.1. Company Overview
17.3.2.2. Source overview
17.3.2.3. SWOT Analysis
17.3.2.4. Key Developments
17.3.3. Glenmark
17.3.3.1. Company Overview
17.3.3.2. Source overview
17.3.3.3. SWOT Analysis
17.3.3.4. Key Developments
17.3.4. Omron Healthcare, Inc.
17.3.4.1. Company Overview
17.3.4.2. Source overview
17.3.4.3. SWOT Analysis
17.3.4.4. Key Developments
17.3.5. GlaxoSmithKline plc.
17.3.5.1. Company Overview
17.3.5.2. Source overview
17.3.5.3. SWOT Analysis
17.3.5.4. Key Developments
17.3.6. Stimwave LLC
17.3.6.1. Company Overview
17.3.6.2. Source overview
17.3.6.3. SWOT Analysis
17.3.6.4. Key Developments
17.3.7. Pfizer
17.3.7.1. Company Overview
17.3.7.2. Source overview
17.3.7.3. SWOT Analysis
17.3.7.4. Key Developments
17.3.8. Stryker Corp.
17.3.8.1. Company Overview
17.3.8.2. Source overview
17.3.8.3. SWOT Analysis
17.3.8.4. Key Developments
17.3.9. AbbVie Inc.
17.3.9.1. Company Overview
17.3.9.2. Source overview
17.3.9.3. SWOT Analysis
17.3.9.4. Key Developments
18. Assumptions And Acronyms Used
19. Research Methodology
Table 1: Global Market Value (US$ Mn) Analysis, by Type, 2018 to 2022Table 2: Global Market Value (US$ Mn) Analysis, by Type, 2023 to 2033
Table 3: Global Market Value (US$ Mn) Opportunity Analysis, by Type, 2023 to 2033
Table 4: Global Market Value (US$ Mn) Analysis, by Treatment, 2018 to 2022
Table 5: Global Market Value (US$ Mn) Analysis, by Treatment, 2023 to 2033
Table 6: Global Market Value (US$ Mn) Opportunity Analysis, by Treatment, 2023 to 2033
Table 7: Global Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 8: Global Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 9: Global Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
Table 10: Global Market Value (US$ Mn) Analysis, by Region, 2018 to 2022
Table 11: Global Market Value (US$ Mn) Analysis, by Region, 2023 to 2033
Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2023 to 2033
Table 13: North America Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 14: North America Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 15: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 16: North America Market Value (US$ Mn) Analysis, by Type, 2018 to 2022
Table 17: North America Market Value (US$ Mn) Analysis, by Type, 2023 to 2033
Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by Type, 2023 to 2033
Table 19: North America Market Value (US$ Mn) Analysis, by Treatment, 2018 to 2022
Table 20: North America Market Value (US$ Mn) Analysis, by Treatment, 2023 to 2033
Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by Treatment, 2023 to 2033
Table 22: North America Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 23: North America Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
Table 25: Latin America Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 26: Latin America Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 27: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 28: Latin America Market Value (US$ Mn) Analysis, by Type, 2018 to 2022
Table 29: Latin America Market Value (US$ Mn) Analysis, by Type, 2023 to 2033
Table 30: Latin America Market Value (US$ Mn) Opportunity Analysis, by Type, 2023 to 2033
Table 31: Latin America Market Value (US$ Mn) Analysis, by Treatment, 2018 to 2022
Table 32: Latin America Market Value (US$ Mn) Analysis, by Treatment, 2023 to 2033
Table 33: Latin America Market Value (US$ Mn) Opportunity Analysis, by Treatment, 2023 to 2033
Table 34: Latin America Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 35: Latin America Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 36: Latin America Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
Table 37: Europe Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 38: Europe Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 39: Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 40: Europe Market Value (US$ Mn) Analysis, by Type, 2018 to 2022
Table 41: Europe Market Value (US$ Mn) Analysis, by Type, 2023 to 2033
Table 42: Europe Market Value (US$ Mn) Opportunity Analysis, by Type, 2023 to 2033
Table 43: Europe Market Value (US$ Mn) Analysis, by Treatment, 2018 to 2022
Table 44: Europe Market Value (US$ Mn) Analysis, by Treatment, 2023 to 2033
Table 45: Europe Market Value (US$ Mn) Opportunity Analysis, by Treatment, 2023 to 2033
Table 46: Europe Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 47: Europe Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 48: Europe Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
Table 49: East Asia Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 50: East Asia Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 51: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 52: East Asia Market Value (US$ Mn) Analysis, by Type, 2018 to 2022
Table 53: East Asia Market Value (US$ Mn) Analysis, by Type, 2023 to 2033
Table 54: East Asia Market Value (US$ Mn) Opportunity Analysis, by Type, 2023 to 2033
Table 55: East Asia Market Value (US$ Mn) Analysis, by Treatment, 2018 to 2022
Table 56: East Asia Market Value (US$ Mn) Analysis, by Treatment, 2023 to 2033
Table 57: East Asia Market Value (US$ Mn) Opportunity Analysis, by Treatment, 2023 to 2033
Table 58: East Asia Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 59: East Asia Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 60: East Asia Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
Table 61: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 62: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 63: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 64: South Asia & Oceania Market Value (US$ Mn) Analysis, by Type, 2018 to 2022
Table 65: South Asia & Oceania Market Value (US$ Mn) Analysis, by Type, 2023 to 2033
Table 66: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Type, 2023 to 2033
Table 67: South Asia & Oceania Market Value (US$ Mn) Analysis, by Treatment, 2018 to 2022
Table 68: South Asia & Oceania Market Value (US$ Mn) Analysis, by Treatment, 2023 to 2033
Table 69: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Treatment, 2023 to 2033
Table 70: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 71: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 72: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
Table 73: MEA Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 74: MEA Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 75: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 76: MEA Market Value (US$ Mn) Analysis, by Type, 2018 to 2022
Table 77: MEA Market Value (US$ Mn) Analysis, by Type, 2023 to 2033
Table 78: MEA Market Value (US$ Mn) Opportunity Analysis, by Type, 2023 to 2033
Table 79: MEA Market Value (US$ Mn) Analysis, by Treatment, 2018 to 2022
Table 80: MEA Market Value (US$ Mn) Analysis, by Treatment, 2023 to 2033
Table 81: MEA Market Value (US$ Mn) Opportunity Analysis, by Treatment, 2023 to 2033
Table 82: MEA Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 83: MEA Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 84: MEA Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
| ※参考情報 感覚障害治療は、paresthesiaと呼ばれる体の一部に異常な感覚をもたらす状態に対する治療方法を指します。感覚障害には、しびれ、チクチク、刺すような感覚、またはまったく感覚がない状態が含まれます。このような症状は、神経の損傷や圧迫、血流の問題、内科的な疾患、さらにはストレスや精神的な要因に起因することがあります。感覚障害は、日常生活に大きな影響を与えることがあり、早期の診断と治療が重要です。 感覚障害の治療は、原因に応じて異なります。まず、神経圧迫が原因の場合、これは手術や物理療法によって解消されることが多いです。たとえば、手根管症候群は、手首の神経が圧迫されることでしびれが生じる状態です。この場合は、手術を通じて神経の圧迫を解除することが考慮されます。また、物理療法によって、筋肉の緊張をほぐし、神経の流れを改善することも役立ちます。 次に、糖尿病などの慢性疾患が原因である場合、血糖コントロールを改善することが最優先となります。糖尿病性神経障害では、血糖値の管理が不十分なために神経が損傷し、感覚障害が生じることがあります。このような場合、食事療法やインスリン治療、経口血糖降下薬などの適切な管理が必要です。 また、特定のビタミン欠乏が原因とされる感覚障害もあります。特にビタミンB12の不足は、多くの神経障害の原因となることが知られています。そのため、サプリメントや食事によって必要なビタミンを補う治療法が考えられます。 関連技術としては、神経刺激装置や鍼治療も挙げられます。神経刺激装置は、微弱な電流を神経に送り、痛みを緩和したり、感覚を回復させたりするためのデバイスです。特に慢性的な痛みや感覚障害に対して有効とされています。鍼治療も、神経を刺激し、血流を改善する方法として広く利用されています。これらの技術は、従来の治療法と併用されることが多く、患者の症状に応じて選択されます。 治療においては、心理的なアプローチも欠かせません。感覚障害がストレスや不安から来ている場合、心理療法やカウンセリングが有効です。リラクゼーション技術やマインドフルネスの導入は、症状の軽減や生活の質の向上に寄与します。 さらに、感覚障害の早期発見と治療のために、症状に気づいたらすぐに医療機関を受診することが重要です。神経の損傷は時間が経つにつれて悪化する可能性があるため、早期の対処が望まれます。また、医療機関では、専門の検査や治療が行われるため、正確な診断が得られます。その結果、状況に応じた最適な治療法が選ばれ、効果的な回復が期待できるのです。 最終的には、感覚障害の治療は多面的であり、原因に応じたアプローチが必要です。医師や専門家とのコミュニケーションを大切にし、患者自身も積極的に治療に取り組む姿勢が、改善に向けた大きな一歩となります。感覚障害がある場合は、一人で悩まず、専門の治療を受けることが重要です。これにより、より快適な日常生活を取り戻すことが可能になります。 |
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/

